Package 49702-246-13

{"route": ["ORAL"], "spl_id": "9b88da25-ebce-49ae-8c8a-dcee6f465957", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["1Q1V9V5WYQ", "2T8Q726O95"], "rxcui": ["2122519", "2122526"], "spl_set_id": ["68e45422-43ed-4cfb-9356-fae88d14a53a"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (49702-246-13)", "package_ndc": "49702-246-13", "marketing_start_date": "20190408"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (49702-246-33)  / 30 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "49702-246-33", "marketing_start_date": "20240101"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (49702-246-62)  / 14 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "49702-246-62", "marketing_start_date": "20240101"}], "brand_name": "Dovato", "product_id": "49702-246_9b88da25-ebce-49ae-8c8a-dcee6f465957", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HIV Integrase Inhibitors [MoA]", "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "49702-246", "generic_name": "dolutegravir sodium and lamivudine", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dovato", "active_ingredients": [{"name": "DOLUTEGRAVIR SODIUM", "strength": "50 mg/1"}, {"name": "LAMIVUDINE", "strength": "300 mg/1"}], "application_number": "NDA211994", "marketing_category": "NDA", "marketing_start_date": "20190408", "listing_expiration_date": "20271231"}